{
    "nct_id": "NCT04721886",
    "official_title": "Interstitial Fluid Pressure Estimation in Breast Cancer Using 3D Subharmonic Signals From Contrast-Enhanced Ultrasound",
    "inclusion_criteria": "* Provide signed and dated informed consent form\n* Be conscious, willing and able to comply with all study procedures and be available for the duration of the study\n* At least 21 years old\n* Be scheduled for a breast biopsy (Breast Imaging Reporting and Data System [BIRAD] 4, 4A, 4B, 4C or 5)\n* Patient with an at least 1 cm mass located at < 3 cm depth, approachable by 2.5 inch needle\n* Be medically stable as determined by the investigator\n* If a female of child-bearing potential, must have a negative urine pregnancy test within 24 hours prior to administration of Definity\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Females who are pregnant or nursing\n* Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example:\n* Patients on life support or in a critical care unit\n* Patients with unstable occlusive disease (e.g., crescendo angina)\n* Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia\n* Patients with uncontrolled congestive heart failure (New York Heart Association [NYHA] class IV)\n* Patients with recent cerebral hemorrhage\n* Patients who have undergone surgery within 24 hours prior to the study sonographic examination\n* Patients with known hypersensitivity or allergy to any component of Definity\n* Patients with unstable cardiopulmonary conditions or respiratory distress syndrome\n* Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension or a history of pulmonary emboli",
    "miscellaneous_criteria": ""
}